Ambulatory care

Recce Pharmaceuticals Announces Expansion of Phase I/II Trial of RECCE® 327 for the Treatment of Diabetic Foot Infections

Retrieved on: 
Tuesday, February 27, 2024

The objective of this trial is to evaluate R327’s potential as a topical broad-spectrum anti-infective treatment.

Key Points: 
  • The objective of this trial is to evaluate R327’s potential as a topical broad-spectrum anti-infective treatment.
  • In the coming months, additional study sites both locally and overseas will become active and include the broader patient population in the study.
  • Of the estimated 537 million people worldwide who have diabetes, 19–34% will develop a DFU in their lifetime.
  • “A non-invasive method to treat the burdensome challenges of diabetic foot ulcer infections gives hope to better patient outcomes and avoid limb amputation, as is so commonly the case with these complicated patients.

Innovaccer’s AI-Cloud for Healthcare Ranked No. 1 Population Health Management Solution in the 2024 Black Book User Survey for Third Consecutive Year

Retrieved on: 
Tuesday, March 5, 2024

It achieved the highest scores in 11 of the most critical categories and was ranked #1 overall with an impressive score of 9.75.

Key Points: 
  • It achieved the highest scores in 11 of the most critical categories and was ranked #1 overall with an impressive score of 9.75.
  • Black Book Research announced Innovaccer as the vendor that received the highest accolades for provider user experience and outcomes in its annual customer survey which evaluated twenty data platforms, data integration, and interoperability solutions.
  • This is the sixth time that Innovaccer has been rated as a top vendor by Black Book Research.
  • "As health systems grapple with the intricacies of population health management, challenges to the data ecosystem within hospitals can impede overall progress," said Doug Brown, president of Black Book Research.

coeus.health Unveils Revolutionary Presence™ & h³c™ Solutions at VIVE

Retrieved on: 
Monday, February 26, 2024

Inaugural revenue for coeus.health is projected to exceed expectations for 2024, chiefly driven by h³c, powered by its platform partners, including Salesforce, BestBuy Health, and valued OEMs.

Key Points: 
  • Inaugural revenue for coeus.health is projected to exceed expectations for 2024, chiefly driven by h³c, powered by its platform partners, including Salesforce, BestBuy Health, and valued OEMs.
  • This innovative solution significantly enhances patient satisfaction, decreases patient leakage, and increases clinic staff job satisfaction while recovering revenue loss.
  • “Access to and communication with medical providers are key drivers of a great patient experience, including better health outcomes.
  • VIVE conference attendees are invited to experience firsthand the transformative potential of Presence and h³c.

Hackensack Meridian Health Breaks Ground On First In the Nation Health & Wellness Center At A Transit Hub, Bringing Comprehensive, Convenient and Easily Accessible Healthcare To New Jersey Transit's Metropark Station

Retrieved on: 
Friday, March 8, 2024

I am pleased to join Hackensack Meridian Health today and applaud their continued work to provide vital health care to the people of New Jersey."

Key Points: 
  • I am pleased to join Hackensack Meridian Health today and applaud their continued work to provide vital health care to the people of New Jersey."
  • When it opens next year, the Hackensack Meridian Health and Wellness Center will offer more than 60,000 square feet of healthcare services just steps from the mass transit hub.
  • "Hackensack Meridian Health is committed to expanding access to quality healthcare, meeting patients where they are," said Robert C. Garrett, chief executive officer of Hackensack Meridian Health.
  • The Hackensack Meridian Health and Wellness Center at Metropark is scheduled to open in 2025.

MCG Releases 28th Edition of Guidelines with New Support for the 2024 Medicare Advantage Final Rule

Retrieved on: 
Tuesday, February 27, 2024

SEATTLE, Feb. 27, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled evidence-based guidance, announces the release of its 28th edition of the MCG care guidelines. Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023.

Key Points: 
  • Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023.
  • - Jon Shreve, President & CEO, MCG Health
    MCG care guidelines are among the most widely used clinical guidelines in the healthcare industry.
  • The updates were designed to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F).
  • In addition, MCG will hold several educational sessions related to the 28th edition at their annual Client Forum in Phoenix, Arizona (April 22-24).

HEALWELL AI’s Intrahealth Provides Update on New Customer Implementation at Canuck Place Children’s Hospice

Retrieved on: 
Thursday, February 15, 2024

Intrahealth is pleased to report on a recent enterprise customer installation at the Canuck Place Children’s Hospice in Vancouver, BC.

Key Points: 
  • Intrahealth is pleased to report on a recent enterprise customer installation at the Canuck Place Children’s Hospice in Vancouver, BC.
  • Canuck Place was a contract that was won through a competitive RFP process.
  • Canuck Place chose Profile because of the ability to easily configure complex workflows especially those related to intake and medications.
  • Profile is the single source of truth to ensure information is consistent across Canuck Place hospice sites and community care in-home and in-hospital.

CipherHealth Announces Self-Service Rounding, Giving Patients Autonomy and Taking Aim at Staff Burnout

Retrieved on: 
Wednesday, February 14, 2024

NEW YORK, Feb. 14, 2024 /PRNewswire/ -- CipherHealth, a recognized leader and innovator in patient-centered communications, engagement, and insights for the nation's leading healthcare systems, today announced a new Self-Service Rounding solution. The solution provides another key tool to hospitals to better empower patients, combat staff burnout, provide more personalized care, and improve workflows.

Key Points: 
  • The solution provides another key tool to hospitals to better empower patients, combat staff burnout, provide more personalized care, and improve workflows.
  • The solution aims to revolutionize patient care and change rounding culture by giving power and voice to patients.
  • By placing an emphasis on patient agency and real-time feedback, Self-Service Rounding allows patients to self-report issues and feedback in the moment.
  • In turn, hospital leaders are able to react faster and get valuable insights into the issues that matter most to patients.

New OmniSYS | XiFin Pharmacy Transformation Study on Future of the Industry Reveals Reimbursement a Top Concern, Even as Service and Expanded Role Opportunities Identified

Retrieved on: 
Wednesday, February 14, 2024

Launched in November 2023, the study delved into pharmacy expansion, garnering key insights from more than 500 respondents representing a wide array of pharmacy professionals and organizations.

Key Points: 
  • Launched in November 2023, the study delved into pharmacy expansion, garnering key insights from more than 500 respondents representing a wide array of pharmacy professionals and organizations.
  • (Graphic: Business Wire)
    Nearly 75% of respondents tagged an expanded role for pharmacists to fill the primary care gaps as a top growth opportunity.
  • However, over 70% of these respondents reported that reimbursement was a barrier to expansion, while 61% said medical billing capabilities were.
  • Barriers to Expansion: Reimbursement challenges, staff shortages, and regulatory limitations were identified as significant barriers to clinical service expansion.

Tenet Reports Fourth Quarter and FY 2023 Results; Provides 2024 Financial Outlook

Retrieved on: 
Thursday, February 8, 2024

Net income from continuing operations available to the Company’s common shareholders in the fourth quarter 2023 was $244 million, or $2.30 per diluted share, versus $102 million, or $0.92 per diluted share, in fourth quarter 2022.

Key Points: 
  • Net income from continuing operations available to the Company’s common shareholders in the fourth quarter 2023 was $244 million, or $2.30 per diluted share, versus $102 million, or $0.92 per diluted share, in fourth quarter 2022.
  • Fourth quarter 2023 included COVID-related stimulus grant income of $2 million pre-tax ($2 million after-tax, or $0.02 per diluted share) versus $40 million pre-tax ($30 million after-tax, or $0.28 per diluted share) in fourth quarter 2022.
  • Adjusted EBITDA1 excluding grant income in fourth quarter 2023 was $1.010 billion compared to $857 million in fourth quarter 2022, reflecting strong volume growth in our Ambulatory Care and Hospital Operations segments, favorable payer mix, as well as improved contract labor costs.
  • Additionally, in the fourth quarter of 2023, the Company recognized a $52 million aggregate favorable pre-tax impact associated with Medicaid supplemental revenue program adjustments in California and Texas.

HEALWELL AI Completes Acquisition of Intrahealth

Retrieved on: 
Thursday, February 1, 2024

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce it has completed the previously announced acquisition of Intrahealth Systems Limited (“Intrahealth”), a former subsidiary of WELL Health Technologies Corp. (“WELL”) (TSX: WELL), which is an insider of the Company (the “Transaction”).

Key Points: 
  • TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce it has completed the previously announced acquisition of Intrahealth Systems Limited (“Intrahealth”), a former subsidiary of WELL Health Technologies Corp. (“WELL”) (TSX: WELL), which is an insider of the Company (the “Transaction”).
  • Dr. Alexander Dobranowski, CEO of HEALWELL, commented on the acquisition, “We are pleased to complete the acquisition of Intrahealth and excited to welcome the Intrahealth team to HEALWELL.
  • Dorian Prior, President of Intrahealth commented, “We are thrilled to join forces with HEALWELL, a trailblazer in AI technology, and excited with the potential of integrating our products with HEALWELL’s cutting-edge AI technologies.
  • As part of the Transaction, HEALWELL, WELL and Intrahealth entered into a Transition Services Agreement to ensure a timely and efficient transition of the services of Intrahealth to HEALWELL.